IP Library Granted Patent US 10,624,982
Granted Patent B2
US 10,624,982 · App. 15/280,240 · Granted Apr 21, 2020

Wound care compositions

Inventors: Steven B. Jung (Rolla, MO); Delbert E. Day (Rolla, MO)
Assignee: The Curators of the University of Missouri
A61L15/18A61F13/00008A61F13/00034A61F13/069A61K33/16A61K33/22A61K33/26A61K33/30A61K33/32A61K33/34A61K33/38A61L15/42A61L15/425A61L15/44A61L15/64A61L17/00A61L26/0004A61L26/0009A61L26/0085A61F2013/00157A61F2013/00221A61F2013/00519A61F2013/00829A61F2013/00936A61K9/0014A61K9/06A61L2300/10A61L2300/102A61L2300/112A61L2300/412A61L2400/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,624,982
App. No.
15/280,240
Granted
Apr 21, 2020
Kind
B2
Abstract

Glass-based particles of a biocompatible material which comprises 40 to about 80 wt % borate (B 2 O 3 ) intermixed into a carrier which is an ointment, cream, or surgical glue.

Claims (45)

1. Glass-based particles of a biocompatible material intermixed into a carrier, wherein the glass-based particles comprise, in wt %:

B 2 O 3

50 to 80

P 2 O 5

 0 to 10

SiO 2

 0 to 18

Al 2 O 3

0 to 3

F

0 to 4

two or more alkali oxides selected from the group consisting of Li 2 O, Na 2 O, K 2 O, and Rb 2 O in a cumulative concentration between 5 and 25 wt %;

two or more alkaline earth oxides selected from the group consisting of MgO, SrO, BaO, and CaO in a cumulative concentration between 1 and 30 wt %;

wherein the glass-based particles comprise from 50 to 80 wt % B 2 O 3 , 1 to 25 wt % Na 2 O, 1 to 25% K 2 O, 1 to 40 wt % CaO, 1 to 25 wt % MgO, and 1 to 10 wt % P 2 O 5 ;

and optionally one or more trace elements selected from the group consisting of Ag, Cu, F, Fe, Mn, Mo, Ni, Sr, and Zn in a concentration between about 0.05 and 10 wt % per trace element chemically dissolved in the biocompatible material;

wherein the carrier is a biocompatible ointment or cream or a surgical glue.

2. The glass-based particles intermixed into a carrier of claim 1 , wherein the glass-based particles comprise said one or more trace elements selected from the group consisting of Ag, Cu, F, Fe, Mn, Mo, Ni, Sr, and Zn in a concentration between about 0.05 and 10 wt % per trace element chemically dissolved in the biocompatible material.

3. The glass-based particles intermixed into a carrier of claim 1 , wherein the carrier is a surgical glue.

4. The glass-based particles intermixed into a carrier of claim 1 wherein Ca concentration in the glass-based particles is controlled to less than 5 wt %.

5. The glass-based particles intermixed into a carrier of claim 1 wherein the glass-based particles comprise said one or more trace elements selected from the group consisting of Ag, Cu, F, Fe, Mn, Mo, Ni, Sr, and Zn in a concentration between about 0.1 and 2.5 wt % per trace element chemically dissolved in glass.

6. The glass-based particles intermixed into a carrier of claim 1 wherein the glass-based particles comprise Cu in a concentration between about 0.05 and 10 wt % chemically dissolved in the glass.

7. The glass-based particles intermixed into a carrier of claim 4 wherein the one or more trace elements comprise Cu in a concentration is between 0.1 and 2.5 wt %.

8. The glass-based particles intermixed into a carrier of claim 4 wherein the one or more trace elements comprise 0.05 to 5 wt % Zn.

9. The glass-based particles intermixed into a carrier of claim 1 wherein the glass-based particles affirmatively comprise the Cu as the trace element in the concentration between about 0.05 and 10 wt %.

10. The glass-based particles intermixed into a carrier of claim 1 wherein the particles comprise microspheres.

11. The glass-based particles intermixed into a carrier of claim 1 wherein the particles are biodegradable.

12. The glass-based particles intermixed into a carrier of claim 1 wherein the glass-based particles have a particle size of between 1 and 300 μm.

13. The glass-based particles intermixed into a carrier of claim 1 wherein the glass-based particles have a particle size of between 3 and 50 μm.

14. The glass-based particles intermixed into a carrier of claim 1 wherein at least 10 wt % of the particles have a first composition and at least 10 wt % of the particles have a second composition different from the first composition.

15. Glass-based particles of a biocompatible material intermixed into a carrier, wherein the glass-based particles consist of, in wt %:

B 2 O 3

50 to 80

P 2 O 5

 0 to 10

SiO 2

 0 to 18

Al 2 O 3

0 to 3

F

0 to 4

two or more alkali oxides selected from the group consisting of Li 2 O, Na 2 O, K 2 O, and Rb 2 O in a cumulative concentration between 5 and 25 wt %;

two or more alkaline earth oxides selected from the group consisting of MgO, SrO, BaO, and CaO in a cumulative concentration between 1 and 30 wt %;

wherein the glass-based particles comprise from 50 to 80 wt % B 2 O 3 , 1 to 25 wt % Na 2 O, 1 to 25% K 2 O, 1 to 40 wt % CaO, 1 to 25 wt % MgO, and 1 to 10 wt % P 2 O 5 ;

and optionally one or more trace elements selected from the group consisting of Ag, Cu, F, Fe, Mn, Mo, Ni, Sr, and Zn in a concentration between about 0.05 and 10 wt % per trace element chemically dissolved in the biocompatible material.

16. The glass-based particles of a biocompatible material intermixed into a carrier of claim 1 , wherein the carrier is an ointment.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 4, 2022
From: MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY
To: THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY
Reel/Frame 058541/0055 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2016
From: JUNG, STEVEN B.; DAY, DELBERT E.
To: THE CURATORS OF THE UNIVERSITY OF MISSOURI
Reel/Frame 039897/0412 →
Continuity (4)
Continuation 14028148 · Sep 16, 2013
Continuation 13442051 · Apr 9, 2012
Continuation 12683244 · Jan 6, 2010
Related Publication 20170014542A1 · Jan 19, 2017
Cited By (1)
US 12,440,503